Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Joves

Physical Medicine & Rehabilitation Sacramento, CA Medical Doctor

NPI 1013201938 CMS profile 1386177

4860 Y St, Suite 3850, Sacramento, CA 95817

Open in the dashboard

General payments

$18,663

414 records reported · program years 2019–2025

Research payments

$460

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$10,784 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Brian Joves of Sacramento, CA is reported in the CMS Open Payments database as having received $18,663 across 414 general payments and $460 in research payments paid to them. Separately, studies naming them as principal investigator received $10,784 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,725 71
2024 General $1,250 38
2023 General $917 26
2022 General $1,409 45
2021 General $731 46
2020 General $6,390 69
2020 Research $460 1
2019 General $6,241 119

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Joves
  • Physical Medicine & Rehabilitation median
  • Middle half of Physical Medicine & Rehabilitation
  • National median

In program year 2025, general payments to Brian Joves were reported at $1,725. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.

Show as a table
Year Brian Joves Physical Medicine & Rehabilitation median Middle half National median
2019 $6,241 $133 $45–$390 $163
2020 $6,390 $88 $29–$272 $114
2021 $731 $116 $33–$360 $132
2022 $1,409 $123 $40–$378 $149
2023 $917 $131 $43–$396 $160
2024 $1,250 $141 $45–$409 $164
2025 $1,725 $139 $48–$410 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic USA, Inc. $9,761 54 payments
  2. Medtronic, Inc. $2,678 89 payments
  3. Abbott Laboratories $1,410 60 payments
  4. Boston Scientific Corporation $1,384 93 payments
  5. Electronic Waveform Lab, Inc. $1,040 37 payments
  6. SI-BONE, Inc. $651 12 payments
  7. Painteq LLC $450 7 payments
  8. Collegium Pharmaceutical, Inc. $183 9 payments
  9. Nevro Corp. $163 10 payments
  10. BIOTRONIK NRO, Inc. $152 2 payments
  11. Other $790 41 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $10,273 406 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $7,900 5 payments
  3. Travel and Lodging $490 3 payments
Products named General payments · program years 2019–2025
  1. ADAPTIVESTIM $4,068 8 payments
  2. INTELLIS $3,750 30 payments
  3. INTELLIS ADAPTIVESTIM $1,949 56 payments
  4. RESTORE $1,885 12 payments
  5. Proclaim Family of SCS IPGs $702 25 payments
  6. INCEPTIV $527 15 payments
  7. PAINTEQ $450 7 payments
  8. IFUSE IMPLANT $405 6 payments
  9. INFINION $309 5 payments
  10. WaveWriter Alpha Prime 16 $275 17 payments
  11. Other $3,312 208 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic USA, Inc. $460 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

176

Median for Physical Medicine and Rehabilitation: 276

Drug cost

$7,562

Median for Physical Medicine and Rehabilitation: $5,921

Branded share of claims

43.8%

Median for Physical Medicine and Rehabilitation: 11.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Buprenorphine Generic 18 $4,689
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 66 $1,576
Gabapentin Generic 53 $712
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 11 $228
Pregabalin Generic 15 $212
Oxycodone Hcl Generic 13 $146

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$828,800

Medicare's payments for the services billed

Medicare patients

1,266

Average age 73

Services billed

6,960

834 women, 432 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 73%
Depression 34%
Diabetes 28%
Ischemic heart disease 27%
Chronic kidney disease 26%
Osteoporosis 23%
COPD 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
XTAMPZA
  • Collegium Pharmaceutical, Inc. $90
$90 — —
RELISTOR
  • Salix Pharmaceuticals, a division of Bausch Health US, LLC $25
$25 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

415 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record